AP2008004468A0 - Pyrazine derivatives as sodium channel modulators for the treatment of pain - Google Patents

Pyrazine derivatives as sodium channel modulators for the treatment of pain

Info

Publication number
AP2008004468A0
AP2008004468A0 AP2008004468A AP2008004468A AP2008004468A0 AP 2008004468 A0 AP2008004468 A0 AP 2008004468A0 AP 2008004468 A AP2008004468 A AP 2008004468A AP 2008004468 A AP2008004468 A AP 2008004468A AP 2008004468 A0 AP2008004468 A0 AP 2008004468A0
Authority
AP
ARIPO
Prior art keywords
pain
treatment
sodium channel
channel modulators
pyrazine derivatives
Prior art date
Application number
AP2008004468A
Other languages
English (en)
Inventor
Cedric Poinsard
Stephen Martin Denton
Karl Richard Et Al Gibson
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of AP2008004468A0 publication Critical patent/AP2008004468A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AP2008004468A 2005-11-04 2006-10-23 Pyrazine derivatives as sodium channel modulators for the treatment of pain AP2008004468A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73366205P 2005-11-04 2005-11-04
PCT/IB2006/003055 WO2007052123A2 (en) 2005-11-04 2006-10-23 Pyrazine derivatives as sodium channel modulators for the treatment of pain

Publications (1)

Publication Number Publication Date
AP2008004468A0 true AP2008004468A0 (en) 2008-06-30

Family

ID=37890558

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2008004468A AP2008004468A0 (en) 2005-11-04 2006-10-23 Pyrazine derivatives as sodium channel modulators for the treatment of pain

Country Status (27)

Country Link
US (1) US7572797B2 (de)
EP (1) EP1945630B1 (de)
JP (1) JP2009514937A (de)
KR (1) KR20080066073A (de)
CN (1) CN101356169A (de)
AP (1) AP2008004468A0 (de)
AR (1) AR057855A1 (de)
AT (1) ATE525372T1 (de)
AU (1) AU2006310215A1 (de)
BR (1) BRPI0618129A2 (de)
CA (1) CA2624621C (de)
CR (1) CR9954A (de)
DO (1) DOP2006000243A (de)
EA (1) EA200801011A1 (de)
EC (1) ECSP088412A (de)
ES (1) ES2371932T3 (de)
GT (1) GT200600475A (de)
IL (1) IL191059A0 (de)
MA (1) MA29926B1 (de)
NL (1) NL2000284C2 (de)
NO (1) NO20082496L (de)
PE (1) PE20070715A1 (de)
TN (1) TNSN08196A1 (de)
TW (1) TW200804353A (de)
UY (1) UY29893A1 (de)
WO (1) WO2007052123A2 (de)
ZA (1) ZA200803671B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0934061B3 (de) 1996-07-24 2015-01-21 Warner-Lambert Company LLC Isobutylgaba und dessen derivate zur schmerzbehandlung
EP1741708A1 (de) * 2005-06-28 2007-01-10 Sanofi-Aventis Deutschland GmbH Heteroaryl substituierte Amide mit ungesättigtem oder zyklischem Linker, und deren Verwendung als Pharmaka
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US20100227872A1 (en) * 2007-05-03 2010-09-09 Mark Ian Kemp Pyrazine derivatives
EA015952B1 (ru) 2007-05-03 2011-12-30 Пфайзер Лимитед 2-пиридинкарбоксамидные производные в качестве модуляторов натриевых каналов
WO2009026434A1 (en) * 2007-08-21 2009-02-26 Alkermes, Inc. Pulmonary pharmaceutical formulations
BRPI0820669A2 (pt) 2007-12-10 2020-08-04 Novartis Ag compostos orgânicos
JPWO2009101917A1 (ja) 2008-02-13 2011-06-09 エーザイ・アール・アンド・ディー・マネジメント株式会社 ビシクロアミン誘導体
JP5791500B2 (ja) 2008-05-23 2015-10-07 パンミラ ファーマシューティカルズ，エルエルシー． ５−リポキシゲナーゼ活性化タンパク質阻害剤
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US10703722B2 (en) 2010-04-27 2020-07-07 Calcimedica, Inc. Compounds that modulate intracellular calcium
WO2013059677A1 (en) * 2011-10-19 2013-04-25 Calcimedica, Inc. Compounds that modulate intracellular calcium
ES2645984T3 (es) * 2012-04-25 2017-12-11 Raqualia Pharma Inc Derivados de pirrolopiridinona como bloqueadores de TTX-S
EP3495359A1 (de) 2013-02-04 2019-06-12 Janssen Pharmaceutica NV Flap-modulatoren
TWI644899B (zh) 2013-02-04 2018-12-21 健生藥品公司 Ｆｌａｐ調節劑
CA2960274A1 (en) * 2014-09-10 2016-03-17 Epizyme, Inc. Isoxazole carboxamide compounds
TWI771269B (zh) 2015-02-27 2022-07-21 美商鈣系醫藥公司 胰腺炎治療
CA2995094A1 (en) * 2015-08-07 2017-02-16 Calcimedica, Inc. Use of crac channel inhibitors for the treatment of stroke and traumatic brain injury
GB201801128D0 (en) 2018-01-24 2018-03-07 Univ Oxford Innovation Ltd Compounds
CA3172249A1 (en) 2020-03-20 2021-09-23 Calcimedica, Inc. Methods and compositions for treating acute lung injury and acute respiratory distress syndrome
JP7791898B2 (ja) 2020-11-13 2025-12-24 カルシメディカ，インク． Ｃｒａｃチャネル阻害剤の合成の改善

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA26473A1 (fr) * 1997-03-01 2004-12-20 Glaxo Group Ltd Composes pharmacologiquement actifs.
DE60234269D1 (de) * 2001-11-21 2009-12-17 Pharmacia & Upjohn Co Llc Substituierte aryl 1,4-pyrazin derivate
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
CA2543644A1 (en) * 2003-10-27 2005-05-06 Astellas Pharma Inc. Pyrazine derivatives and pharmaceutical use thereof
CN101084208A (zh) * 2004-10-22 2007-12-05 詹森药业有限公司 作为c－fms激酶抑制剂的芳族酰胺

Also Published As

Publication number Publication date
ZA200803671B (en) 2009-03-25
TW200804353A (en) 2008-01-16
MA29926B1 (fr) 2008-11-03
PE20070715A1 (es) 2007-08-11
CR9954A (es) 2008-05-28
EA200801011A1 (ru) 2009-02-27
ATE525372T1 (de) 2011-10-15
CA2624621C (en) 2010-11-30
WO2007052123A2 (en) 2007-05-10
DOP2006000243A (es) 2007-05-31
EP1945630A2 (de) 2008-07-23
GT200600475A (es) 2007-07-06
US20070105872A1 (en) 2007-05-10
BRPI0618129A2 (pt) 2011-08-16
TNSN08196A1 (fr) 2009-10-30
NL2000284A1 (nl) 2007-05-07
NO20082496L (no) 2008-07-24
EP1945630B1 (de) 2011-09-21
JP2009514937A (ja) 2009-04-09
ECSP088412A (es) 2008-05-30
AU2006310215A1 (en) 2007-05-10
UY29893A1 (es) 2007-06-29
ES2371932T3 (es) 2012-01-11
CA2624621A1 (en) 2007-05-10
IL191059A0 (en) 2008-12-29
KR20080066073A (ko) 2008-07-15
AR057855A1 (es) 2007-12-19
US7572797B2 (en) 2009-08-11
CN101356169A (zh) 2009-01-28
WO2007052123A3 (en) 2007-07-12
NL2000284C2 (nl) 2007-09-28

Similar Documents

Publication Publication Date Title
IL191059A0 (en) Pyrazine derivatives as sodium channel modulators for the treatment of pain
IL191832A0 (en) Pyridiazinone derivatives for the treatment of tumours
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
SI2024368T1 (sl) Derivati 6,7,8,9-tetrahidro-5h-pirimido(4,5-d)azepin-4-il)-amina kot modulatorji trpv 1 za zdravljenje boleäśine
IL188430A0 (en) Treatment of tumors
IL192627A0 (en) Prolinamide derivatives as sodium channel modulators
AP2007004157A0 (en) N- (N-sulfonylaminomethyl) cyclo-propanecarboxamide derivatives useful for the treatment of pain
GB0715745D0 (en) Liquid formulations for treatment of diseases or conditions
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
ZA200802762B (en) Pharmaceutical compositions for the treatment of inner ear disorders
EP1928452A4 (de) Verwendung von natriumkanalblockern zur behanldung von viszeralen schmerzen oder schmerzen durch krebsbehandlung
GB0909297D0 (en) Composition for the treatment of skin conditions
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
EP1867640A4 (de) Mittel zur behandlung fester tumore
PL1959957T3 (pl) Pochodne pirymidyloaminobenzamidu do leczenia neurowłókniakowatości
IL187792A0 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of cancer
EP1871372A4 (de) Kombinationstherapie mit einem calciumkanalblocker vom n-typ zur schmerzminderung
GB0517387D0 (en) Combinations for the treatment of cancer
ZA200805522B (en) Dioxoiane dérivates for the treatment of cancer
EP1900363A4 (de) Therapeutisches mittel gegen schmerzen
GB0505203D0 (en) Skin composition treatment
HUP0500947A2 (en) Composition for treatment of paradontosis
HK1122032A (en) Benzoisoindole derivatives for the treatment of pain
ZA200806180B (en) Benzoisoindole derivatives for the treatment of pain
GB0517386D0 (en) Combinations for the treatment of cancer